FFA
COGT icon

Farther Finance Advisors’s Cogent Biosciences COGT Stock Holding History

Farther Finance Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.78K Buy
118
+2
+2% +$74 ﹤0.01% 5147
2026
Q2 		$4.49K Buy
116
+2
+2% +$70 ﹤0.01% 4853
2026
Q1 		$4.02K Buy
114
+8
+8% +$295 ﹤0.01% 4597
2025
Q4 		$3.77K Buy
106
+30
+39% +$843 ﹤0.01% 4448
2025
Q3 		$1.09K Sell
76
-671
-90% -$7.95K ﹤0.01% 4342
2025
Q2 		$5.36K Buy
747
+395
+112% +$2.19K ﹤0.01% 3333
2025
Q1 		$2.04K Buy
352
+257
+271% +$2.02K ﹤0.01% 3383
2024
Q4 		$741 Hold
95
– – ﹤0.01% 3344
2024
Q3 		$1.03K Hold
95
– – ﹤0.01% 3236
2024
Q2 		$849 Buy
95
+10
+12% +$76 ﹤0.01% 3126
2024
Q1 		$587 Buy
85
+79
+1,317% +$488 ﹤0.01% 2966
2023
Q4 		$35 Buy
+6
New +$46 ﹤0.01% 3416

Other funds holding COGT

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Farther Finance Advisors's COGT Position: Q3 2026 in Review

Farther Finance Advisors increased its Cogent Biosciences (COGT) stake by 1.7% in Q3 2026, buying an estimated $74 and bringing the position to 118 shares worth $3.78K. The position accounts for ﹤0.01% of the portfolio, ranked #5147.

Farther Finance Advisors first reported a position in COGT in Q4 2023 and has held it in 12 quarters since. The position peaked at $5.36K in Q2 2025. 6 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • Farther Finance Advisors held 118 shares of Cogent Biosciences worth $3.78K as of Q3 2026.
  • Farther Finance Advisors bought 2 Cogent Biosciences shares in Q3 2026, an estimated $74.
  • Cogent Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5147 holding.
  • Farther Finance Advisors first reported a position in Cogent Biosciences in Q4 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's Cogent Biosciences position peaked at $5.36K in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.